Modality.AI, Inc. has developed the first multimodal assessment platform to track the progression of neurological and psychiatric diseases through the analysis of facial and vocal metrics, using a virtual agent to guide participants through standardized protocols. Modality’s audiovisual biomarkers expedite the development of therapies. Modality is venture-backed and based in San Francisco, CA.